/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Sandra E. Dunn

Muscular Dystrophy UK(GB)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

214

Papers

7.7K

Citations

49

h-index

78

i10-index

Sandra E. Dunn is an academic researcher from Muscular Dystrophy UK. The author has contributed to research in topics: Glioma Diagnosis and Treatment & RNA Research and Splicing & Neurogenesis and neuroplasticity mechanisms. The author has an h-index of 49, co-authored 182 publications.

Research Topics

Glioma Diagnosis and Treatment RNA Research and Splicing Neurogenesis and neuroplasticity mechanisms Cancer Cells and Metastasis HER2/EGFR in Cancer Research

Papers by this author

works

Identification of ROCK1 kinase as a critical regulator of Beclin1-mediated autophagy during metabolic stress

2013 · Nature Communications · 157 citations

https://doi.org/10.1038/ncomms3189

Aditi U. Gurkar Kiki Chu Lakshmi Raj Richard Bouley

Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2

2006 · Cancer Research · 156 citations

https://doi.org/10.1158/0008-5472.can-05-3561

Joyce C. Wu Cathy Lee Daniel Yokom Helen Jiang

Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy

2007 · Breast Cancer Research · 145 citations

https://doi.org/10.1186/bcr1767

Anna L. Stratford Golareh Habibi Arezoo Astanehe Helen Jiang

Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

2008 · Breast Cancer Research · 122 citations

https://doi.org/10.1186/bcr2156

Golareh Habibi Samuel Leung Jennifer Law Karen A. Gelmon

Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells

2012 · Breast Cancer Research · 88 citations

https://doi.org/10.1186/bcr3107

Kaiji Hu Jennifer Law Abbas Fotovati Sandra E. Dunn

Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived Phosphoinositide-Dependent Kinase-1 Inhibitor

2006 · Molecular Pharmacology · 80 citations

https://doi.org/10.1124/mol.106.023911

Ping‐Hui Tseng Yu-Chieh Wang Shu-Chuan Weng Jing‐Ru Weng

Research topics

topics

Glioma Diagnosis and Treatment

RNA Research and Splicing

Neurogenesis and neuroplasticity mechanisms

Cancer Cells and Metastasis

HER2/EGFR in Cancer Research

Chat about Author

Papers

Chat

Click to start Chat